Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study (Q34783837)

4 August 2017

title

Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study (English)

1 reference

4 August 2017

1 reference

10

Steven A Narod

1 reference

4 August 2017

Kelly A Metcalfe

1

1 reference

4 August 2017

Isabel Fan

2

1 reference

4 August 2017

John McLaughlin

3

1 reference

4 August 2017

Harvey A Risch

4

1 reference

4 August 2017

Barry Rosen

5

1 reference

4 August 2017

Joan Murphy

6

1 reference

4 August 2017

Linda Bradley

7

1 reference

4 August 2017

Susan Armel

8

1 reference

4 August 2017

Ping Sun

9

1 reference

4 August 2017

language of work or name

English

0 references

publication date

20 November 2008

1 reference

4 August 2017

1 reference

4 August 2017

volume

112

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

68-72

1 reference

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074978

Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074978

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074978

Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074978

Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074978

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074978

Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074978

A fluorescent multiplex-DGGE screening test for mutations in the BRCA1 gene.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074978

Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074978

An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation?

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074978

Prevalence and Predictors ofBRCA1andBRCA2Mutations in a Population-Based Study of Breast Cancer in White and Black American Women Ages 35 to 64 Years

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074978

BRCA1/2 predictive testing: a study of uptake in two centres

9 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074978

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2Mutation

9 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3074978

A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes

9 December 2018

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2008.10.007

Identification of specific BRCA1 and BRCA2 variants by DHPLC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2008.10.007

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2008.10.007

Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2008.10.007

Utilization of BRCA1/2 genetic testing in the clinical setting: report from a single institution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2008.10.007

Factors associated with decisions about clinical BRCA1/2 testing

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19019415

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19019415

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2008.10.007

1 reference

4 August 2017

1 reference

4 August 2017

1 reference